Opioid therapy overuse in disease-free cancer survivors is cost inefficient and negatively impacts quality-adjusted life years (QALYs), when compared to rapid low-dose discontinua ...

Healthcare has become a battleground for both political parties. Robert Costa, national correspondent for "CBS News Sunday Morning" and chief Washington analyst for CBS News, said today at the ...

Migraine and cluster headache autoinjector treatment Brekiya (dihydroergotamine mesylate) is now available by prescription through Walgreens Specialty Pharmacy and Sterling Specia ...

When equipped with real-time data and integrated into the care team, pharmacists and pharmacy benefit managers can proactively identify health risks, support care coordination, and close medication ...

Type A botulinum, commonly reffered to as botox, was approved by FDA in 2002 for cosmetic use to reduce fine lines and ...

In the VALOR trial, brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared ...

In this first segment from an interview with Managed Healthcare Executive about his presentation about trends in aesthetic ...

Fifty-four percent of patients ages 12 to 18 with severe alopecia noticed hair regrowth when given 4-mg of Olumiant (oral baricitinib), according to results of a study presented this week at the 2025 ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...

Each Sunday we feature a highlight reel of various articles posted on our website that week.

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...